...
首页> 外文期刊>Acta pharmaceutica: a quarterly journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, dealing with all branches of pharmacy and allied sciences >Use of 2-aminoprop-1-ene-1,1,3-tricarbonitrile for the synthesis of tetrahydronaphthalene, hexahydroisoquinoline and hexahydrocinnoline derivatives with potential antitumor activities.
【24h】

Use of 2-aminoprop-1-ene-1,1,3-tricarbonitrile for the synthesis of tetrahydronaphthalene, hexahydroisoquinoline and hexahydrocinnoline derivatives with potential antitumor activities.

机译:2-氨基丙-1-烯-1,1,3-三碳腈在合成具有潜在抗肿瘤活性的四氢萘,六氢异喹啉和六氢肉桂碱衍生物中的用途。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of the work was to synthesize heterocyclic compounds from 2-aminoprop-1-ene-1,1,3-tricarbonitrile and to study their antitumor activities. The title reagent reacted with cyclohexanone to give the ethylidene derivative 2. The reactivity of the latter product towards different chemical reagents was studied to give tetrahydronaphthalene, hexahydroisoquinoline and hexahydrocinnoline derivatives. The newly synthesized products were screened as antitumor agents on the in vitro growth of three human tumor cell lines representing different tumor types, namely, breast adenocarcinoma (MCF-7), non-small cell lung cancer (NCI-H460) and CNS cancer (SF-268). It was found that some of these compounds showed inhibitory effects on the three cell lines, indicating their potential use in the development of oncology products.
机译:该工作的目的是从2-氨基丙-1-烯-1,1,3-三碳腈合成杂环化合物并研究其抗肿瘤活性。标题试剂与环己酮反应,得到亚乙基衍生物2。研究了后者产物对不同化学试剂的反应性,得到了四氢萘,六氢异喹啉和六氢辛啉衍生物。在代表三种不同肿瘤类型的三种人类肿瘤细胞系,即乳腺癌,腺癌(NCI-H460)和中枢神经系统癌(NCI-H460)的体外生长中,筛选了新合成的产物作为抗肿瘤药。 SF-268)。发现这些化合物中的一些对三种细胞系显示出抑制作用,表明它们在肿瘤学产品开发中的潜在用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号